Medical Advisory Committee members are all senior hepatologists with wide ranging expertise in the field of liver disease. The MAC supports the decision making of the Trust where medical knowedge and experience are required. They perform a vital role in keeping the Trust on track and up to date (Powers & Duties.doc).
Professor Humphrey Hodgson graduated from Oxford University in 1966 and has been the Sheila Sherlock Professor of Medicine at the Royal Free and University College, School of Medicine and Director of the Royal Free’s Centre for Hepatology since 1999. He has also been Vice-Dean and Campus Director at the Royal Free since 2000.
Humphrey has published numerous research papers relating to many aspects of liver disease.
Dr Alison Brind is Consultant Physician in the department of Gastroenterology at Stoke on Trent’s City General Hospital. Having trained as a hepatologist in Newcastle-upon-Tyne and at King's in London, Dr. Brind completed a locum consultant post in the Western Australia transplant unit, Perth. Since then she has enjoyed working in non-transplant hepatology in a busy acute Trust with her major clinical interest in all forms of liver disease including alcohol, NASH, HCV and HBV. She also runs sessions at a viral hepatitis clinic at the Queen Elizabeth Hospital in Birmingham.
Research projects have included alpha-1-antitrypsin and hbv and more recently been related to genetic susceptibility to alcoholic liver disease (ALD).
Dr Jane Collier has been Consultant Hepatologist at the John Radcliffe Hospital in Oxford since 2000. She trained in Newcastle-upon-Tyne at the transplant unit and in Toronto.
As well as carrying out research in hepatocellular carcinoma, her areas of expertise are in general hepatology, managing liver transplant follow ups, alcoholic liver disease and chronic viral hepatitis. She also runs joint speciality clinics in cystic fibrosis and HIV disease.
Professor Chris Day is currently Professor of Liver Medicine in the School of Clinical Medical Sciences of the University of Newcastle upon Tyne and Honorary Consultant Hepatologist in the Liver Unit at the Freeman Hospital, Newcastle upon Tyne.
Apart from being a member of the British Liver Trust Medical Advisory Committee, Professor Day is also a member of the British Association of the Study of the Liver, the Scientific Committee of the European Association for the Study of the Liver and on the Editorial Boards of GUT, Hepatology and Liver International.
He is currently Secretary of the Royal College of Physicians (UK) Alcohol Committee and is currently on the UK Government’s Medical Advisory Panel on driving and alcohol. Prior to his appointment as Chair of Liver Medicine, he was supported for seven years by the Medical Research Council (UK) for research into alcoholic liver disease. In 1999 he was awarded the Goulstonian Lectureship of the Royal College of Physicians UK, and in 2000 the British Society of Gastroenterology Sir Frances Avery Jones research gold medal.
Professor Day’s specialist subject areas include genetic susceptibility, the natural history and pathogenesis of alcoholic liver disease, drug-induced liver disease and non-alcoholic fatty liver disease.
Dr Jan Freeman is Consultant Hepatologist at Derby City Hospital. A member of the British Association for the Study of the Liver and Secretary of the British Society of Gastroenterology Liver Section, he is currently active in a research programme dealing with portal hypertension and hepatic renal syndrome.
In addition, Jan is a member of the Centre for Integrated Science and Medicine and a clinical teacher at the University of Nottingham.
Professor Ian Gilmore has been Consultant Physician and Gastroenterologist at the Royal Liverpool University Hospital since 1980 and Honorary Professor at the University of Liverpool since 1999. He trained at King’s College, Cambridge and St. Thomas’ Hospital, London and was an MRC Travelling Fellow at the University of California San Diego from 1979-1980.
Professor Ian Gilmore is President of the Royal College of Physicians and Chairman of the Alcohol Committee. He is also a member of the Secretary of State’s advisory group on drugs and alcohol, DVLA and sits on the expert panel on vaccine interactions for the MoD.
Ian now works exclusively in hepatology and biliary disease and has particular expertise and interest in alcoholic liver disease and the wider aspects of alcohol misuse.
Dr Mark Hudson is Consultant Hepatologist at the Freeman Hospital in Newcastle-upon-Tyne. He qualified in Medicine at Aberdeen University and trained in gastroenterology and hepatology in Aberdeen, at the Royal Free, the Freeman and King’s College hospitals. He was appointed Consultant Physician and Hepatologist to Newcastle Hospitals Trust in 1995 and is Lead Physician at the Freeman's regional liver and transplant unit.
Mark's special interests include liver transplantation, portal hypertension, primary sclerosing cholangitis and hepatocellular carcinoma.
Professor James Neuberger qualified at Oxford University in 1978. After House jobs in London he worked as a Senior House Officer and subsequently as a Registrar in Leeds before returning to London where he spent ten years at the Liver Unit in King’s College Hospital. In 1989, he was appointed to the Liver Unit at the Queen Elizabeth Hospital, Birmingham, where he is Professor of Hepatology.
James is also Editor of Transplantation magazine and Associate Editor of Liver International journal He is also Chairman of the Medical Advisory Committee of the PBC Foundation.
His particular interests are liver transplantation, primary biliary cirrhosis and other auto-immune diseases.
Professor William Rosenberg is a graduate of the University of Cambridge and studied clinical medicine at Guy’s Hospital, London. He trained at MRC Clinical Research Centre, Northwick Park Hospital, the Royal Brompton Hospital and the University of Oxford where, at the latter, he studied gastroenterology and hepatology.
He moved to Southampton in 1997 and is a director of the Wellcome Trust Clinical Research Facility there. He is currently working on developing immuno-therapies for viral hepatitis and participates in numerous clinical trials of treatment for hepatitis C.
William has a particular clinical interest in diagnostic testing in chronic liver disease and has also set up a liver clinical epidemiology group which has established the British Liver Disease Clinical Research Network.
Dr Ken Simpson is Senior Lecturer and Honorary Consultant Physician at the New Royal Infirmary in Edinburgh where there is also a liver transplant unit. He has particular expertise in transplantation, acute liver failure and alcoholic liver disease and specific research interest in liver inflammation, regeneration and fibrosis.
Ken is Secretary of the British Association for the Study of the Liver (BASL).
Dr Paul Smith is a retired gastroenterologist. He qualified in London and was appointed as Medical Registrar in Southampton in 1965. He was a Research Fellow at the Liver Unit of King’s College Hospital and at the Department of Gastroenterology, Boston University, USA, returning as Senior Medical Registrar at University College Hospital. In 1972 Paul moved to the Welsh National School of Medicine, first as Senior Lecturer in Medicine and until 2001 as Consultant Gastroenterologist.
Paul's special interests include haemochromatosis and variceal haemorrhage. He has been Medical Director of the British Liver Trust since 2004.
Professor Mark Thursz is a Professor of Hepatology and Consultant Gastroenterologist at St. Mary’s Hospital, London and Reader in Medicine at Imperial College. He has been Secretary of the British Association for Study of the Liver (BASL) since 2002.
Mark has a clinical interest in the management of hepatitis infection and his research interests are focused on the immunology and genetics of persistent infections.